<DOC>
	<DOCNO>NCT01118819</DOCNO>
	<brief_summary>This protocol examine safety intravenous administration Clostridium novyi-NT spore patient treatment-refractory solid tumor malignancy . This investigational study measure anti-tumor activity C. novyi-NT administer intravenously patient treatment-refractory solid tumor malignancy .</brief_summary>
	<brief_title>Safety Study Clostridium Novyi-NT Spores Treat Patients With Solid Tumors That Have Not Responded Standard Therapies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>1 . Diagnosis advance solid tumor malignancy 2 . History prior treatment least one line systemic anticancer therapy , approve systemic therapy available , curative option available continued treatment . 3 . Measurable disease define RECIST 1.1 criterion . 4 . At least 4 week elapse since completion major surgery patient fully recover surgery postsurgical complication . 5 . ECOG performance status 2 less . 6 . Patient least 18 year age 7 . Patient capable give informed consent . 8 . Patient childbearing potential ( defined clinical site ' standard ) use adequate birth control measure ( e.g. , barrier method spermicide ; intrauterine device ; implantable injectable hormonal contraceptive ; surgical sterilization ) duration study continue use precaution 12 month receive treatment . 9 . Patient significant valvular disease ( trace mild valvular stenosis regurgitation allow ) . 10 . Patient able stay within 45 minute drive time emergency room 28 day follow discharge . 11 . The patient caregiver 28 day dose . 1 . Positive pregnancy test 2 . Serum creatinine level &gt; 1.5 x upper limit normal ( ULN ) , chronic renal failure require hemodialysis peritoneal dialysis . 3 . Patient follow hematologic parameter : Platelet count equal less 100,000/mm3 , Hemoglobin le 9.0 g/dL , ANC le 1,000 /mm3 . 4 . Oxygen saturation ( Sp02 ) less 95 % room air . 5 . Mean arterial blood pressure le 70 mmHg . 6 . Glasgow Coma Score less 15 . 7 . Treatment investigational drug within past 30 day 5 halflives drug . 8 . Documented evidence primary brain malignancy brain metastasis . 9 . Clinically significant ascites clinical evidence history portosystemic hypertension cirrhosis . 10 . Laboratory evidence hepatic dysfunction indicate follow : bilirubin &gt; 1.5 x upper limit normal , AST ALT 2.5X upper limit normal , alkaline phosphatase 2.5X upper limit normal INR great 1.3 . 11 . Patient foreign body opinion treat investigator could difficult manage case infection ( e.g . prosthetic hip ) . 12 . Clinically significant pleural effusion . 13 . Clinically significant pericardial effusion , circumferential pericardial effusion , effusion great 1.0 cm location around heart . 14 . Need ongoing treatment immunosuppressive agent . 15 . History solid organ transplantation ( exception corneal transplant &gt; 3 month prior screen ) . 16 . History ischemic insult previous 12 month ( myocardial infarction , cerebral vascular accident , ischemic tissue injury , transient ischemic attack , clinically significant peripheral vascular disease ) . 17 . Patient history venous stasis result venous stasis ulcer &gt; 2+ edema . 18 . History significant medical illness deem principal investigator local investigator unsuitable trial example : i. Symptomatic congestive heart failure ; ii . Psychiatric Illness/Social Situation may make study dangerous ; iii . Unstable angina pectoris . 19 . Asplenia . 20 . Antibiotic allergy would preclude treatment C. novyiNT infection , event antibiotic require . 21 . Treatment antibiotic within 2 week ( 14 day ) dose . 22 . Active clinically significant systemic localize infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Phase I</keyword>
	<keyword>Metastatic Disease</keyword>
	<keyword>Solid Tumor</keyword>
	<keyword>Malignancy</keyword>
	<keyword>Metastases</keyword>
	<keyword>Clinical trial</keyword>
	<keyword>Hypoxia</keyword>
	<keyword>Necrosis</keyword>
</DOC>